Cholintransport

Cholintransport, or choline transport, refers to the cellular processes by which choline is moved across membranes into cells to support acetylcholine synthesis and phospholipid metabolism. It involves multiple transporter protein families with tissue-specific distribution, allowing choline to be taken up from the extracellular space in both neural and non-neural tissues.

In the nervous system, the presynaptic cholinergic neuron relies on the high-affinity choline transporter CHT1 (SLC5A7). CHT1 is a sodium-dependent transporter located on the plasma membrane and represents a rate-limiting step for acetylcholine production, linking choline uptake to neuronal firing and synaptic transmission. Genetic mutations affecting CHT1 can contribute to certain congenital myasthenic syndromes and reduced cholinergic function.

Beyond CHT1, other transporters contribute to choline uptake in various tissues. Choline transporter-like proteins (CTL1/SLC44A1, CTL2/SLC44A2, and related isoforms CTL3) mediate choline uptake in non-neuronal cells and barrier tissues, often with a broader substrate range. Organic cation transporters (OCTs; SLC22 family) can also move choline, particularly in contexts where high-affinity uptake is less prominent. In the gut, liver, and other organs, CTLs and OCTs support choline acquisition from the extracellular environment.

Inside cells, choline fulfills multiple roles: it is a substrate for acetylcholine synthesis via choline acetyltransferase, and it participates in phosphatidylcholine production through the Kennedy pathway. In non-neuronal cells, choline can contribute to methyl group metabolism after oxidation to betaine.

Regulation of cholintransport depends on neuronal activity, membrane potential, transporter expression, and pharmacological modulation. Clinically, defects or dysregulation of choline transport can affect cholinergic signaling and are investigated in neuromuscular and neurodegenerative contexts, as well as in drug-delivery research.